Zhou YF - Search Results

1

The role of CXC cytokines as biomarkers and potential targets in hepatocellular carcinoma.

Wang YH, Huang JH, Tian ZF, Zhou YF, Yang J. Wang YH, et al. Among authors: zhou yf. Math Biosci Eng. 2019 Nov 22;17(2):1381-1395. doi: 10.3934/mbe.2020070. Math Biosci Eng. 2019. PMID: 32233584 Free article.

2

OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of ERK/MAPK Pathway.

Li H, Miao Q, Xu CW, Huang JH, Zhou YF, Wu MJ. Li H, et al. Among authors: zhou yf. J Korean Med Sci. 2016 Aug;31(8):1215-23. doi: 10.3346/jkms.2016.31.8.1215. Epub 2016 Jun 3. J Korean Med Sci. 2016. PMID: 27478331 Free PMC article.

3

Circular RNA Circ100084 functions as sponge of miR‑23a‑5p to regulate IGF2 expression in hepatocellular carcinoma.

Yang J, Li Y, Yu Z, Zhou Y, Tu J, Lou J, Wang Y. Yang J, et al. Mol Med Rep. 2020 Jun;21(6):2395-2404. doi: 10.3892/mmr.2020.11069. Epub 2020 Apr 10. Mol Med Rep. 2020. PMID: 32323783 Free PMC article.

4

Expression of CD133 protein in osteosarcoma and its relationship with the clinicopathological features and prognosis.

Xie Y, Huang J, Wu M, Zhou Y. Xie Y, et al. J Cancer Res Ther. 2018;14(4):892-895. doi: 10.4103/jcrt.JCRT_461_17. J Cancer Res Ther. 2018. PMID: 29970672 Free article.

5

Relationship Between PD-L1 Expression and Clinical Characteristics in Patients with Breast Invasive Ductal Carcinoma.

Lou J, Zhou Y, Huang J, Qian X. Lou J, et al. Open Med (Wars). 2017 Sep 6;12:288-292. doi: 10.1515/med-2017-0042. eCollection 2017. Open Med (Wars). 2017. PMID: 28894845 Free PMC article.

6

Molecular and clinical analysis of Chinese patients with anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer.

Zhou X, Shou J, Sheng J, Xu C, Ren S, Cai X, Chu Q, Wang W, Zhen Q, Zhou Y, Li W, Pan H, Li H, Sun T, Cheng H, Wang H, Lou F, Rao C, Cao S, Pan H, Fang Y. Zhou X, et al. Cancer Sci. 2019 Oct;110(10):3382-3390. doi: 10.1111/cas.14177. Epub 2019 Sep 23. Cancer Sci. 2019. PMID: 31444835 Free PMC article.

7

Napabucasin Attenuates Resistance of Breast Cancer Cells to Tamoxifen by Reducing Stem Cell-Like Properties.

Liu X, Huang J, Xie Y, Zhou Y, Wang R, Lou J. Liu X, et al. Med Sci Monit. 2019 Nov 24;25:8905-8912. doi: 10.12659/MSM.918384. Med Sci Monit. 2019. PMID: 31760402 Free PMC article.

8

Pemetrexed-based chemotherapy for non-small-cell lung cancer patients with EGFR exon 20 insertion mutation: a multicenter study.

Xu CW, Wang WX, Wang D, Wang QM, Pu XX, Zhu YC, Huang JH, Yu ZY, Cui ZL, Chen XH, Li JL, Fang Y, Wang H, Zhuang W, Lan SJ, Cai X, Zhang YB, Gao WB, Wang LP, She KL, Rao CZ, Zhou YF, Fang MY, Miao LY, Lei L, Lv TF, Song Y. Xu CW, et al. Among authors: zhou yf. Transl Lung Cancer Res. 2020 Oct;9(5):1853-1861. doi: 10.21037/tlcr-20-382. Transl Lung Cancer Res. 2020. PMID: 33209607 Free PMC article.

9

CEP72-ROS1: A novel ROS1 oncogenic fusion variant in lung adenocarcinoma identified by next-generation sequencing.

Zhu YC, Zhou YF, Wang WX, Xu CW, Zhuang W, Du KQ, Chen G. Zhu YC, et al. Among authors: zhou yf. Thorac Cancer. 2018 May;9(5):652-655. doi: 10.1111/1759-7714.12617. Epub 2018 Mar 8. Thorac Cancer. 2018. PMID: 29517860 Free PMC article.

10

Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic upper gastrointestinal cancers.

Zheng Y, Mislang ARA, Coward J, Cosman R, Cooper A, Underhill C, Zhu J, Xiong J, Jiang O, Wang H, Xie Y, Zhou Y, Jin X, Li B, Wang ZM, Kwek KY, Xia D, Xia Y, Xu N. Zheng Y, et al. Cancer Immunol Immunother. 2022 Oct;71(10):2371-2379. doi: 10.1007/s00262-022-03160-1. Epub 2022 Feb 15. Cancer Immunol Immunother. 2022. PMID: 35165764 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

908 results

Search Page